Presearch Market Capitalization Hits 41.68 Million
PRE Stock | USD 4.30 0.18 4.02% |
About 61% of Prenetics Global's investor base is looking to short. The analysis of the overall prospects from investing in Prenetics Global suggests that many traders are, at the present time, alarmed. The current market sentiment, together with Prenetics Global's historical and current headlines, can help investors time the market. In addition, many technical investors use Prenetics Global stock news signals to limit their universe of possible portfolio assets.
Prenetics |
Presearch traded up 22.3 percent against the U.S. dollar during the twenty-four hour period ending at 1700 PM Eastern on March 31st. During the last week, Presearch has traded down 9.3 percent against the U.S. dollar. Presearch has a market cap of 41.68 million and 722,120.50 worth of Presearch was traded on exchanges in the last
Read at thelincolnianonline.com
Prenetics Global Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Prenetics Global can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Prenetics Global Fundamental Analysis
We analyze Prenetics Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prenetics Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prenetics Global based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Prenetics Global is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Prenetics Global Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prenetics Global stock to make a market-neutral strategy. Peer analysis of Prenetics Global could also be used in its relative valuation, which is a method of valuing Prenetics Global by comparing valuation metrics with similar companies.
Peers
Prenetics Global Related Equities
XGN | Exagen | 12.17 | ||||
NOTV | Inotiv | 7.44 | ||||
BNR | Burning Rock | 0.99 | ||||
FONR | Fonar | 0.12 | ||||
QGEN | Qiagen NV | 0.82 | ||||
MDXH | MDxHealth | 1.01 | ||||
CSTL | Castle Biosciences | 1.97 | ||||
DRIO | DarioHealth Corp | 2.60 | ||||
ACRS | Aclaris Therapeutics | 2.78 | ||||
NEOG | Neogen | 3.78 | ||||
SERA | Sera Prognostics | 4.89 | ||||
BDSX | Biodesix | 5.56 |
Complementary Tools for Prenetics Stock analysis
When running Prenetics Global's price analysis, check to measure Prenetics Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prenetics Global is operating at the current time. Most of Prenetics Global's value examination focuses on studying past and present price action to predict the probability of Prenetics Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prenetics Global's price. Additionally, you may evaluate how the addition of Prenetics Global to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |